Xilio Therapeutics, Inc. (XLO)
8.37
-0.20
(-2.33%)
USD |
NASDAQ |
Apr 20, 09:51
Xilio Therapeutics SG&A Expense (Quarterly) : 7.40M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Johnson & Johnson | 0.00 |
| Merck & Co., Inc. | 2.898B |
| Pfizer Inc. | 4.162B |
| Verastem, Inc. | 24.44M |
| Sensei Biotherapeutics, Inc. | 0.00 |